Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study
- PMID: 21701925
- DOI: 10.1245/s10434-011-1852-7
Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study
Abstract
Purpose: The existing literature suggests that the postoperative mortality (POM) rate in radical cystectomy (RC) patients does not exceed 3%. We sought to develop and externally validate a reference table that quantifies POM after RC.
Methods: We identified 12,274 patients treated with RC, between 1998 and 2007, within the Nationwide Inpatient Sample database. A total of 6188 (50.4%) randomly selected patients was used as the development cohort. Logistic regression analysis for prediction of POM adjusted for: age, sex, race, Charlson comorbidity index (CCI), urinary diversion type, year of surgery, annual hospital caseload, location/teaching status of hospital, region and bed size of hospital. The reference table was developed by using stepwise variable removal to identify the most accurate and parsimonious model. The model was externally validated in 6086 (49.6%) patients.
Results: POM occurred in 2.4% of patients. POM proportion increased with increasing age (≤59: 0.6% vs. 60-69: 1.6% vs. 70-79: 3.1% vs. ≥80: 4.6%, P < 0.001), and higher CCI (CCI 0: 1.7% vs. CCI 1: 3.0% vs. CCI 2: 4.2% vs. CCI 3: 4.3% vs. CCI ≥ 4: 12.1%, P < 0.001). In multivariable analyses, only age and CCI remained as independent predictors of POM, after stepwise variable removal. The discrimination accuracy of the reference table in predicting POM was 70%.
Conclusions: Age and CCI represent the foremost determinants of POM after RC. The developed reference table is capable of predicting POM after RC, in an individualized fashion. The accuracy of the model is good (70%), and it is highly generalizable.
Similar articles
-
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.Ann Surg Oncol. 2011 Sep;18(9):2680-7. doi: 10.1245/s10434-011-1618-2. Epub 2011 Feb 23. Ann Surg Oncol. 2011. PMID: 21347778
-
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.J Urol. 2011 Sep;186(3):824-8. doi: 10.1016/j.juro.2011.04.066. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788051
-
A population based assessment of perioperative mortality after cystectomy for bladder cancer.J Urol. 2009 Jul;182(1):70-7. doi: 10.1016/j.juro.2009.02.120. Epub 2009 May 17. J Urol. 2009. PMID: 19447427
-
Contemporary 90-day mortality rates after radical cystectomy in the elderly.Eur J Surg Oncol. 2014 Dec;40(12):1738-45. doi: 10.1016/j.ejso.2014.10.004. Epub 2014 Oct 15. Eur J Surg Oncol. 2014. PMID: 25454826
-
An electronic application for rapidly calculating Charlson comorbidity score.BMC Cancer. 2004 Dec 20;4:94. doi: 10.1186/1471-2407-4-94. BMC Cancer. 2004. PMID: 15610554 Free PMC article. Review.
Cited by
-
Perioperative factors and 30-day major complications following radical cystectomy: A single-center study in Thailand.Heliyon. 2024 Jun 22;10(13):e33476. doi: 10.1016/j.heliyon.2024.e33476. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39027524 Free PMC article.
-
Feasibility and safety of laparoscopic radical cystectomy for male octogenarians with muscle-invasive bladder cancer.BMC Cancer. 2024 Jan 31;24(1):159. doi: 10.1186/s12885-024-11816-7. BMC Cancer. 2024. PMID: 38297199 Free PMC article.
-
Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center.Int Braz J Urol. 2023 May-Jun;49(3):351-358. doi: 10.1590/S1677-5538.IBJU.2022.0405. Int Braz J Urol. 2023. PMID: 37115179 Free PMC article.
-
Muscle invasive bladder cancer and radical cystectomy: a risk predictive model.Ecancermedicalscience. 2022 Oct 18;16:1456. doi: 10.3332/ecancer.2022.1456. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36405942 Free PMC article.
-
Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.PLoS One. 2021 Jun 18;16(6):e0252925. doi: 10.1371/journal.pone.0252925. eCollection 2021. PLoS One. 2021. PMID: 34143813 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
